Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CLVLY Relative to the S&P 500

CLVLY Relative to the Sector

Seasonal Chart Analysis

Analysis of the Clinuvel Pharmaceuticals Ltd. (OTCMKT:CLVLY) seasonal charts above shows that a Buy Date of November 28 and a Sell Date of April 15 has resulted in a geometric average return of 6.05% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 10.25% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.

To download CLVLY seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CLVLY